Form to be used for the disclosure of the total number of voting rights and capital,
in accordance with the law and grand-ducal regulation of 11 January 2008 on
transparency requirements for issuers of securities
Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedi (including the issuer ID allocated by the CSSF)
EUROFINS SCIENTIFIC SE - E1013
Identity of the notifier (if another person makes the notification on behalf of the issuer) N/ A
Total number of shares composing the share capital of the notifying issuer
191,174,963
Total number of voting rights attached to the shares composing the share capital of the notifying issuer, including the suspended voting rightsii
319,275,373
Origin of the changeiii
• Exercise of stock options and warrants
Date when the change occurred
30 April 2021
Either the full name of the legal entity or another method for identifying the issuer or underlying issuer, provided it is reliable and accurate.
For further details on the total number of voting rights, please refer to point 1(b) of circular CSSF 08/349.
As, for example, a capital increase or reduction.
Attachments
Original document
Permalink
Disclaimer
Eurofins Scientific SE published this content on 05 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 May 2021 16:20:04 UTC.
Eurofins Scientific SE is one of the world's leading providers of bio-analytical services. The group's services are intended to validate the safety, authenticity, origin, identity, and purity of biological substances contained in the environment (water, air, soil, etc.) and in food, pharmaceutical, cosmetic, and hygiene products.
At the end of 2023, Eurofins Scientific SE owned a portfolio of over 200,000 analytical methods and had 900 laboratories located throughout the world.
Net sales are distributed geographically as follows: Europe (50.7%), North America (38.5%) and other (10.8%).